Complement Deficiency Follow-up
- Author: Ruchir Agrawal, MD; Chief Editor: Russell W Steele, MD more...
Deterrence/Prevention
- Prevention of infections and immediate treatment are important aspects of treatment in patients with complement deficiency. Treat acute infections with appropriate antibiotics and prevent with vaccination.
- All routine vaccines are recommended. Meningococcal, pneumococcal, and haemophilus vaccinations are recommended for patients and those who are in close contact with them.
Prognosis
- Properdin deficiency is associated with a high mortality rate.
Garred P, Pressler T, Madsen HO, et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest. Aug 1999;104(4):431-7. [Medline].
Tedesco F. Inherited complement deficiencies and bacterial infections. Vaccine. Dec 30 2008;26 Suppl 8:I3-8. [Medline].
Janzi M, Sjoberg R, Wan J, Fischler B, et al. Screening for C3 deficiency in newborns using microarrays. PLoS ONE. 2009;4(4):e5321. [Medline].
[Best Evidence] Jansen AG, Sanders EA, Hoes AW, van Loon AM, Hak E. Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial. J Pediatr. Dec 2008;153(6):764-70. [Medline].
AAP 2000 Red Book. Report of the Committee on Infectious Diseases. 25th ed. 2000:56-7.
Bonilla FA, Bernstein IL, Khan DA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. May 2005;94(5 Suppl 1):S1-63. [Medline].
Carroll MC. CD21/CD35 in B cell activation. Semin Immunol. Aug 1998;10(4):279-86. [Medline].
Cicardi M, Castelli R, Zingale LC, Agostoni A. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol. Feb 1997;99(2):194-6. [Medline].
Cohen J. Meningococcal disease as a model to evaluate novel anti-sepsis strategies. Crit Care Med. Sep 2000;28(9 Suppl):S64-7. [Medline].
Endo M, Ohi H, Ohsawa I, et al. Complement activation through the lectin pathway in patients with Henoch-Schonlein purpura nephritis. Am J Kidney Dis. Mar 2000;35(3):401-7. [Medline].
Frank MM. Complement deficiencies. Pediatr Clin North Am. Dec 2000;47(6):1339-54. [Medline].
Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA. Feb 1 1995;273(5):383-9. [Medline].
Kang HJ, Kim HS, Lee YK, et al. High incidence of complement C9 deficiency in Koreans. Ann Clin Lab Sci. 2005;35(2):144-8. [Medline].
Kumar A, Gupta R, Varghese T, et al. Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus. Indian J Med Res. Dec 1999;110:190-3. [Medline].
Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol. Apr 2006;117(4):904-8. [Medline].
Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol. 2004;22:431-56. [Medline].
Moroni G, Trendelenburg M, Del Papa N, et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis. Mar 2001;37(3):490-8. [Medline].
Notarangelo L, Casanova JL, Conley ME, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol. Apr 2006;117(4):883-96. [Medline].
Ratnoff WD. Inherited deficiencies of complement in rheumatic diseases. Rheum Dis Clin North Am. Feb 1996;22(1):75-94. [Medline].
Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore). Sep 1984;63(5):243-73. [Medline].
Rougier N, Kazatchkine MD, Rougier JP, et al. Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol. Dec 1998;9(12):2318-26. [Medline].
Salzman MB, Rubin LG. Meningococcemia. Infect Dis Clin North Am. Dec 1996;10(4):709-25. [Medline].
Sjoholm AG, Jonsson G, Braconier JH, et al. Complement deficiency and disease: an update. Mol Immunol. Jan 2006;43(1-2):78-85. [Medline].
Sturfelt G, Truedsson L. Complement and its breakdown products in SLE. Rheumatology (Oxford). Oct 2005;44(10):1227-32. [Medline].
Sullivan KE. Genetics of systemic lupus erythematosus. Clinical implications. Rheum Dis Clin North Am. May 2000;26(2):229-56, v-vi. [Medline].
Ten RM, Carmona EM, Babovic-Vuksanovic D, Katzmann JA. Mannose-binding lectin deficiency associated with neutrophil chemotactic unresponsiveness to C5a. J Allergy Clin Immunol. Aug 1999;104(2 Pt 1):419-24. [Medline].
U. S. Department of Health and Human Services. Control and Prevention of Meningococcal Disease and Control and Prevention of Serogroup C Meningococcal Disease: Evaluation and Mangement of Suspected Outbreaks. Morbidity and Mortality Weekly Report. February 14, 1997;46:[Full Text].
Walport MJ. Complement. First of two parts. N Engl J Med. Apr 5 2001;344(14):1058-66. [Medline].
Walport MJ. Complement. Second of two parts. N Engl J Med. Apr 12 2001;344(15):1140-4. [Medline].
Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med. Jun 20 1996;334(25):1630-4. [Medline].
Weiss SJ, Ahmed AE, Bonagura VR. Complement factor D deficiency in an infant first seen with pneumococcal neonatal sepsis. J Allergy Clin Immunol. Dec 1998;102(6 Pt 1):1043-4. [Medline].
Wen L, Atkinson JP, Giclas PC. Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol. Apr 2004;113(4):585-93; quiz 594. [Medline].
West CD, McAdams AJ. The alternative pathway C3 convertase and glomerular deposits. Pediatr Nephrol. Jun 1999;13(5):448-53. [Medline].
Whaley K, Ruddy S. Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. Science. Sep 10 1976;193(4257):1011-3. [Medline].
Wiertsema SP, Herpers BL, Veenhoven RH, et al. Functional polymorphisms in the mannan-binding lectin 2 gene: effect on MBL levels and otitis media. J Allergy Clin Immunol. Jun 2006;117(6):1344-50. [Medline].
Williams DG. C3 nephritic factor and mesangiocapillary glomerulonephritis. Pediatr Nephrol. Feb 1997;11(1):96-8. [Medline].

